Observational studyClinical rheumatology2026

Real-world effectiveness and safety of apremilast in psoriatic arthritis: results from the multicenter Italian MAPSI II study.

Carlotta Schenone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.